Provided by Tiger Trade Technology Pte. Ltd.

AKESO

109.100
+3.4003.22%
Volume:10.62M
Turnover:1.13B
Market Cap:100.48B
PE:-88.50
High:110.400
Open:105.700
Low:102.100
Close:105.700
52wk High:156.000
52wk Low:80.200
Shares:921.00M
HK Float Shares:921.00M
Volume Ratio:2.14
T/O Rate:1.15%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-1.233
ROE:-13.59%
ROA:-4.57%
PB:10.10
PE(LYR):-88.50
PS:24.84

Loading ...

Movement Alert|Akeso Bio Falls 3.24% in Regular Trading, Biotech Sector Broadly Retreats After Recent Rally

Market Focus
·
Jul 07

Movement Alert|Akeso Rises 3.32% in Regular Trading, Innovative Drug Payment Reform Continues to Catalyze Amid Sector-Wide Strength

Market Focus
·
Jul 06

Movement Alert|Akeso Inc Rises 4.8% in Regular Trading, Innovative Drug Payment Reform Catalyzes Biotech Sector Rally

Market Focus
·
Jul 03

Movement Alert|Akeso Bio Rises 6.3% in Regular Trading, Biotech Sector Rally and AI Drug Platform Progress Fuel Rebound

Market Focus
·
Jul 02

Movement Alert|Akeso Falls 3.06% in Regular Trading, Technical Profit-Taking After Previous Session 13% Rally Amid Sector-Wide Weakness

Market Focus
·
Jun 30

Akeso Shareholders Back 2025 Financial Statements at Annual Meeting

Reuters
·
Jun 29

Innovative Drug Sector Surges, Leading Market Rebound with Key ETFs and Stocks Soaring

Deep News
·
Jun 29

Movement Alert|Akeso Bio Rises 3.66% in Regular Trading, Ivonescimab Tops Evaluate Global Most Valuable Pipeline Ranking

Market Focus
·
Jun 29

Movement Alert|Akeso Falls 3.16% in Regular Trading, Post-ASCO Profit-Taking Continues as Stock Nears 52-Week Low

Market Focus
·
Jun 26

Movement Alert|Akeso Falls 3.43% in Regular Trading, Post-ASCO Profit-Taking Persists as Biotech Sector Weakens Again

Market Focus
·
Jun 25

Movement Alert|Akeso Rises 3.1% in Regular Trading, Multiple Brokerages Issue Buy Ratings Amid Biotech Sector Rebound

Market Focus
·
Jun 24

Hong Kong Stocks Surge: Innovative Drug Sector Rallies on Regulatory Report and New Foreign Investment Policies

Stock News
·
Jun 23

China Securities Research Initiates Coverage on AKESO with a "Buy" Rating, Citing Multiple Growth Drivers

Stock News
·
Jun 23

Movement Alert|Akeso Rises 3.44% in Regular Trading, Buyback Support and Broker Buy Rating Trigger Rebound Near 52-Week Low

Market Focus
·
Jun 23

Movement Alert|Akeso Inc Falls 3.88% in Regular Trading, Sustained Selling Pressure Post-ASCO Data as Buyback Fails to Reverse Trend

Market Focus
·
Jun 22

Akeso (SEHK:9926) Stock Could Be 49% Undervalued After New AML Trial Data

Simply Wall St.
·
Jun 19

Movement Alert|Akeso Rises 3.64% in Regular Trading, Industry Buyback Wave and Sector Oversold Rebound Support Price Stabilization

Market Focus
·
Jun 18

Akeso says Phase II trial shows ligufalimab plus azacitidine, venetoclax extends event-free survival in frontline AML

Reuters
·
Jun 17

Movement Alert|Akeso Falls 3.41% in Regular Trading, Buyback Plan Fails to Halt Post-ASCO Profit-Taking Pressure

Market Focus
·
Jun 16

Akeso enrolls first patient in Phase Ib/II study of HER3 ADC AK138D1 plus ivonescimab in advanced breast cancer

Reuters
·
Jun 15